Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $166,750,023.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Paul Vigano sold 14,500,002 shares of the stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $166,750,023.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Trading Up 0.2%

Shares of AVAH opened at $13.62 on Thursday. Aveanna Healthcare Holdings Inc. has a 12-month low of $5.93 and a 12-month high of $13.98. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. The firm has a market capitalization of $2.97 billion, a price-to-earnings ratio of 11.07, a P/E/G ratio of 0.85 and a beta of 1.90. The stock’s 50-day moving average price is $9.95 and its 200 day moving average price is $8.03.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The firm had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million. As a group, research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.75 earnings per share for the current year.

Hedge Funds Weigh In On Aveanna Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of AVAH. Caitong International Asset Management Co. Ltd grew its position in Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after acquiring an additional 2,400 shares during the period. C M Bidwell & Associates Ltd. acquired a new position in Aveanna Healthcare during the second quarter worth $69,000. Summit Securities Group LLC bought a new position in shares of Aveanna Healthcare during the first quarter valued at $53,000. Quantbot Technologies LP bought a new position in shares of Aveanna Healthcare during the second quarter valued at $43,000. Finally, Freestone Grove Partners LP acquired a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at $73,000. Institutional investors own 87.96% of the company’s stock.

Analyst Ratings Changes

AVAH has been the subject of several research reports. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. UBS Group boosted their price target on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a report on Friday, August 14th. Raymond James Financial increased their price objective on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a research note on Friday, August 14th. Wall Street Zen downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Finally, Royal Bank Of Canada lifted their target price on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $12.89.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.